Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
14 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1199 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1204 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1454 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2019-12-09 | 2025-01-23 | 100550 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2019-12-09 | 2025-01-23 | 100553 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100556 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2019-12-09 | 2025-03-20 | 100559 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100562 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100565 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110761 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119883 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-03-04 | 2022-05-19 | 156073 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-08-18 | 2022-10-01 | 167215 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2025-05-15 | 2025-06-13 | 257538 |
| TEVA-PERINDOPRIL | 2MG | TABLET | Resolved | 2025-10-10 | 2025-11-06 | 269249 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Actual shortage | 2025-11-27 | 2025-12-11 | 272760 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 4MG 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110703 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2020-08-13 | 2020-10-22 | 122211 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140396 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153162 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |